LT4491B - 1,4-dihidro-1,4-diokso-1h-naftaleno triciklinių darinių panaudojimas, naujų junginių gavimas ir jų taikymas vaistų gamyboje - Google Patents

1,4-dihidro-1,4-diokso-1h-naftaleno triciklinių darinių panaudojimas, naujų junginių gavimas ir jų taikymas vaistų gamyboje Download PDF

Info

Publication number
LT4491B
LT4491B LT98-085A LT98085A LT4491B LT 4491 B LT4491 B LT 4491B LT 98085 A LT98085 A LT 98085A LT 4491 B LT4491 B LT 4491B
Authority
LT
Lithuania
Prior art keywords
dihydro
dioxo
thiazole
naphtho
novel compound
Prior art date
Application number
LT98-085A
Other languages
English (en)
Lithuanian (lt)
Other versions
LT98085A (en
Inventor
Odile Boutherin-Falson
Stephanie Desquand-Billiald
Anita Favrou
Michel Finet
Olivier Tembo
Jean-Luc Torregrosa
Sylvie Yannic-Arnoult
Florence Domagala-Le-Marquer
Original Assignee
Laboratoire Innothera, Societe Anonyme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Innothera, Societe Anonyme filed Critical Laboratoire Innothera, Societe Anonyme
Publication of LT98085A publication Critical patent/LT98085A/xx
Publication of LT4491B publication Critical patent/LT4491B/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/24—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings
    • C07C225/26—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings
    • C07C225/30—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings of condensed quinone ring systems formed by two rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C46/00—Preparation of quinones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/24—Quinones containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
    • C07C50/32—Quinones containing groups having oxygen atoms singly bound to carbon atoms the quinoid structure being part of a condensed ring system having two rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/60—Naphthoxazoles; Hydrogenated naphthoxazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/84—Naphthothiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/12—One of the condensed rings being a six-membered aromatic ring the other ring being at least seven-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LT98-085A 1995-12-12 1998-06-10 1,4-dihidro-1,4-diokso-1h-naftaleno triciklinių darinių panaudojimas, naujų junginių gavimas ir jų taikymas vaistų gamyboje LT4491B (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9514683A FR2742153B1 (fr) 1995-12-12 1995-12-12 Utilisation de derives tricycliques du 1,4-dihydro-1,4- dioxo-1h-naphtalene, nouveaux composes obtenus et leur application en therapeutique

Publications (2)

Publication Number Publication Date
LT98085A LT98085A (en) 1998-11-25
LT4491B true LT4491B (lt) 1999-04-26

Family

ID=9485393

Family Applications (1)

Application Number Title Priority Date Filing Date
LT98-085A LT4491B (lt) 1995-12-12 1998-06-10 1,4-dihidro-1,4-diokso-1h-naftaleno triciklinių darinių panaudojimas, naujų junginių gavimas ir jų taikymas vaistų gamyboje

Country Status (26)

Country Link
US (1) US6262095B1 (hu)
EP (1) EP0876356B1 (hu)
JP (1) JP2000501724A (hu)
KR (1) KR19990072080A (hu)
AP (1) AP889A (hu)
AR (1) AR005054A1 (hu)
AT (1) ATE207907T1 (hu)
AU (1) AU716199B2 (hu)
BR (1) BR9611935A (hu)
CA (1) CA2240279A1 (hu)
CZ (1) CZ181198A3 (hu)
DE (1) DE69616598D1 (hu)
EE (1) EE9800174A (hu)
FR (1) FR2742153B1 (hu)
HU (1) HUP9901247A3 (hu)
ID (1) ID16081A (hu)
IL (1) IL124558A0 (hu)
LT (1) LT4491B (hu)
LV (1) LV12188B (hu)
NO (1) NO982696L (hu)
NZ (1) NZ323967A (hu)
OA (1) OA10696A (hu)
PL (1) PL327168A1 (hu)
RU (1) RU2178791C2 (hu)
TR (1) TR199801069T2 (hu)
WO (1) WO1997021684A1 (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003999A (en) * 1997-12-19 1999-07-12 Advanced Research And Technology Institute, Inc. Modulators of ryanodine receptors comprising 2-(aryl)-4,7-dioxobenzothiazoles and analogues thereof
ATE318812T1 (de) * 2000-12-21 2006-03-15 Bristol Myers Squibb Co Thiazolyl-inhibitoren von tyrosinkinasen der tec- familie
TWI402261B (zh) 2006-06-19 2013-07-21 Takeda Pharmaceutical 三環化合物及其醫藥組成物
WO2007149484A2 (en) 2006-06-20 2007-12-27 Dana-Farber Cancer Institute Inhibitors of usp1 deubiquitinating enzyme complex
WO2011137320A2 (en) 2010-04-30 2011-11-03 Dana-Farber Cancer Institute, Inc. Small molecule inhibitors of usp1 deubiquitinating enzyme activity
US9040713B2 (en) * 2010-09-27 2015-05-26 Emory University Methods of managing blood sugar levels and compositions related thereto
US9725425B1 (en) 2014-02-25 2017-08-08 Dana-Farber Cancer Institute, Inc. Compounds and methods for treating cancer
RU2545091C1 (ru) * 2014-03-18 2015-03-27 Федеральное государственное бюджетное учреждение "Российский онкологический научный центр имени Н.Н. Блохина" Российской академии медицинских наук (ФГБУ "РОНЦ им. Н.Н. Блохина" РАМН) 1-R-4,9-ДИОКСО-1H-НАФТО[2,3-d][1,2,3]ТРИАЗОЛ-4-ОКСИМ-2-ОКСИДЫ И ИХ ПРОИЗВОДНЫЕ, ОБЛАДАЮЩИЕ ЦИТОТОКСИЧЕСКОЙ АКТИВНОСТЬЮ
US10829427B2 (en) 2015-12-18 2020-11-10 The Board Of Regents Of The University Of Texas System Naphthoquinones, pro-drugs, and methods of use thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3039925A (en) 1957-04-24 1962-06-19 Bayer Ag Compositions for the treatment of tuberculosis
JPS61251657A (ja) 1984-09-12 1986-11-08 ユ−エスヴイ−　フア−マシユ−テイカル　コ−ポレ−シヨン 抗高血圧性誘導体類

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05112533A (ja) * 1991-05-08 1993-05-07 Upjohn Co:The イミダゾベンゾキノン類およびこれを有効成分とする高血圧・鬱血性心不全の予防・治療剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3039925A (en) 1957-04-24 1962-06-19 Bayer Ag Compositions for the treatment of tuberculosis
JPS61251657A (ja) 1984-09-12 1986-11-08 ユ−エスヴイ−　フア−マシユ−テイカル　コ−ポレ−シヨン 抗高血圧性誘導体類

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
F. I. CARROLL ANDJ. T. BLACKWELL: "Synthesis of 1H-naphth[2,3-d]imidazole-4,9-diones by acid catalyzed cyclization of 2-Acylamino-3-amino-1,4-naphthoquinone", JOURNAL OF HETEROCYCLIC CHEMISTRY, 1969, pages 909 - 916
JOHN R. E. HOOVER, ALLAN R. DAY: "Preparation of Some Imidazole Derivatives of 1,4-Naphthoquinone", J. AM. CHEM. SOC., 1954, pages 4148 - 4152, XP002030731, DOI: doi:10.1021/ja01645a028

Also Published As

Publication number Publication date
BR9611935A (pt) 1999-05-18
WO1997021684A1 (fr) 1997-06-19
NO982696L (no) 1998-08-11
JP2000501724A (ja) 2000-02-15
FR2742153B1 (fr) 1998-02-13
OA10696A (fr) 2002-11-26
KR19990072080A (ko) 1999-09-27
NO982696D0 (no) 1998-06-11
AP889A (en) 2000-11-17
EP0876356A1 (fr) 1998-11-11
AU1101897A (en) 1997-07-03
CA2240279A1 (fr) 1997-06-19
EE9800174A (et) 1998-12-15
LV12188A (lv) 1998-12-20
AU716199B2 (en) 2000-02-24
LT98085A (en) 1998-11-25
PL327168A1 (en) 1998-11-23
DE69616598D1 (de) 2001-12-06
NZ323967A (en) 2000-06-23
ID16081A (id) 1997-09-04
US6262095B1 (en) 2001-07-17
AR005054A1 (es) 1999-04-07
FR2742153A1 (fr) 1997-06-13
ATE207907T1 (de) 2001-11-15
TR199801069T2 (xx) 1998-08-21
HUP9901247A3 (en) 2000-08-28
CZ181198A3 (cs) 1998-09-16
HUP9901247A2 (hu) 1999-08-30
EP0876356B1 (fr) 2001-10-31
LV12188B (en) 1999-07-20
IL124558A0 (en) 1998-12-06
AP9801275A0 (en) 1998-06-30
RU2178791C2 (ru) 2002-01-27

Similar Documents

Publication Publication Date Title
CN112601750B (zh) Ptpn11（shp2）抑制剂
CA2935317C (en) 1,2-naphthoquinone based derivative and method of preparing the same
JP6356334B2 (ja) 新規なインデン誘導体、その調製方法、及びそれを有効成分として含有する網膜疾患を予防又は処置するための医薬組成物
CN105392788B (zh) 用作沉默调节蛋白调节剂的取代的桥连脲类似物
JP6688372B2 (ja) キヌレニン−３−モノオキシゲナーゼ阻害薬、医薬組成物、及びこれらの使用方法
JP2004520273A (ja) Ｐａｒｐの阻害剤として用いるためのチエノ［２，３−ｃ］イソキノリン
JP2015500212A (ja) ポリ（ａｄｐ−リボース）ポリメラーゼ阻害剤
TW201908306A (zh) 作為ask抑制劑的雜環化合物及其應用
KR20000052738A (ko) 1-페닐피라졸 화합물 및 그 약학적 용도
JP3290664B2 (ja) ３環性ベンゾアゼピンおよびベンゾチアゼピン誘導体
AU2021208915B2 (en) Novel pyrazole derivative
LT4491B (lt) 1,4-dihidro-1,4-diokso-1h-naftaleno triciklinių darinių panaudojimas, naujų junginių gavimas ir jų taikymas vaistų gamyboje
CN106317057A (zh) 具有咪唑并吡嗪类衍生物,其制备及其在医药上的应用
NZ238648A (en) Substituted benzoxazole derivatives and pharmaceutical compositions
EP3129102A1 (en) Iodonium analogs as inhibitors of nadph oxidases and other flavin dehydrogenases; formulations thereof; and uses thereof
CN111164087B (zh) 有助于抑制人三叶因子3的化合物
JP2000502081A (ja) １，４―ジヒドロ―１，４―ジオキソナフタレンのヘテロ芳香族及び三環式誘導体の利用、得られる新規化合物並びにその治療用途
JP4965428B2 (ja) セミカルバジド誘導体を含むフリーラジカル消去剤
JP2000502334A (ja) モノまたはジケトン二環式化合物の誘導体の使用、それにより得られた化合物、並びに炎症、片頭痛およびショックの治療用薬剤としてのそれらの用途
WO2021200934A1 (ja) 抗マラリア薬
MXPA98004717A (es) Utilizacion de derivados triciclicos de 1,4-dihidro-1,4-dioxo-1h-naftaleno, nuevos compuestos obtenidos y su aplicacion terapeutica
TWI410246B (zh) 用於治療敗血症的八苯基異喹啉衍生物及其醫藥組成物
JPH0755939B2 (ja) 新規なベンゾチアゾリノン誘導体
KR20240110273A (ko) 새로운 인돌리진-피롤로피리미딘 하이브리드 유도체 제조방법 및 이를 포함하는 항암제 조성물
WO2022228489A1 (zh) Hpk1抑制剂及其在医药上的应用

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20021210